Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

Infection

Volumn 22, Issue 2, 1994, Pages 81-85

  Verweij, P E ^a   Meis, J F G M ^a   Donnelly, J P ^a   De Pauw, B E ^a   Kullberg, B J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CREATININE; FLUCYTOSINE;

ADULT; AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FUNGEMIA; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; NEUTROPHIL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTEMIC MYCOSIS;

EID: 0002704356     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/BF01739009     Document Type: Article

References (31)

1. Opportunistic fungal infections in patients with neoplastic disease
2. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy
3. Bacteremia and fungemia in patients with neoplastic disease
4. Candida and Aspergillus infections in immunocompromised patients
5. Prolonged granulocytopenia; the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia
6. Fungal infections in cancer patients: an international autopsy survey
7. Diagnosing fungal infections in immunocompromised patients
8. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host
9. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study
10. Treatment of systemic fungal infections: recent progress and current problems
11. Ultrasonography and computed tomography of hepatic candidiasis in immunosuppressed patients
12. Hepatic candidiasis in cancer patients: The evolving picture of the syndrome
13. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
14. Empiric antifungal therapy in febrile neutropenic patients
15. Empiric therapy with amphotericin B in febrile granulocytopenic patients
16. Recurrent reversible acute renal failure from amphotericin
17. Flucytosine
18. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice
19. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis
20. Combination therapy for systemic mycosis
21. Combination therapy for systemic mycosis
22. Treatment of invasive aspergillosis: relation to early diagnosis and treatment to response
23. Fungemia in the immuno-compromised host: changing patterns, antigenemia, high mortality
24. Fungal infections in patients with acute leukemia
25. Empiric amphotericin B therapy in patients with acute leukemia
26. Hepatic candidiasis: an increasing problem in immunocompromised patients
27. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases
28. Systemic candidiasis in cancer patients
29. Fluconazole therapy for disseminated candidiasis in patients with leukemia and prior amphotericin B therapy
30. Treatment of hepatosplenic candidiasis with liposomal amphotericin B
31. The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B